Abstract
Free full text
The Collaborative Cross-Mouse Population for Studying Genetic Determinants Underlying Alveolar Bone Loss Due to Polymicrobial Synergy and Dysbiosis
Abstract
Dysbiosis of oral microbiota is associated with the initiation and progression of periodontitis. The cause-and-effect relationship between genetics, periodontitis, and oral microbiome dysbiosis is poorly understood. Here, we demonstrate the power of the collaborative cross (CC) mice model to assess the effect of the genetic background on microbiome diversity shifts during periodontal infection and host suitability status. We examined the bacterial composition in plaque samples from seven different CC lines using 16s rRNA sequencing before and during periodontal infection. The susceptibility/resistance of the CC lines to alveolar bone loss was determined using the micro-CT technique. A total of 53 samples (7 lines) were collected before and after oral infection using oral swaps followed by DNA extraction and 16 s rRNA sequencing analysis. CC lines showed a significant variation in response to the co-infection (p < 0.05). Microbiome compositions were significantly different before and after infection and between resistant and susceptible lines to periodontitis (p < 0.05). Gram-positive taxa were significantly higher at the resistant lines compared to susceptible lines (p < 0.05). Gram-positive bacteria were reduced after infection, and gram-negative bacteria, specifically anaerobic groups, increased after infection. Our results demonstrate the utility of the CC mice in exploring the interrelationship between genetic background, microbiome composition, and periodontitis.
1. Introduction
Periodontitis is one of the most common chronic infectious diseases worldwide [1]. Untreated severe periodontitis cases may cause tooth loss. It is evident that susceptibility to periodontitis is attributed to an interplay of the host genetic background with environmental factors and disturbances of the oral microbiome [1,2,3,4,5,6]. Accordingly, periodontitis is regarded as a “dysbiositic disease”. Dysbiosis is a condition in which the balanced state of the ecosystem is disturbed. The hypothesis suggests that the transition from periodontal health to disease reflects a significant alteration in the number and community organization of the oral commensal bacteria in the periodontal pocket. This shift in the microbial community composition leads to alterations in the host–microbe crosstalk sufficient to mediate destructive inflammation and bone loss [7,8]. Different studies suggested that this shift may be mediated by environmental factors and/or keystone pathogens such as Porphyromonas gingivalis (P.g.) [9,10,11,12,13,14].
In the last decades, numerous studies evaluated the alterations in oral microbiota composition across different stages of periodontal disease. However, only a few studies have assessed the cause-and-effect relationship between periodontal disease severity, the genetic constitution of the host, and alterations in the composition of the oral microbiota. Using appropriate animal models could overcome these limitations and contribute significantly to an improved understanding of the relationship between alterations in the composition of the oral microbiota and the genetic architecture of periodontitis susceptibility.
The ideal mouse model to study complex diseases with complex etiologies mimics the complex genetic diversity among populations and enables the fine mapping of quantitative trait loci (QTLs) underlying defined complex phenotypes [15]. In recombinant inbred line (RIL) crosses of genetically defined strains, chromosomal regions responsible for the genetic variance of complex traits can be mapped as QTLs under defined conditions [16,17,18,19]. To address these requirements, a new genetic resource population, named the collaborative cross (CC) mouse model, was proposed by community efforts.
The CC is a RIL mouse population that was specifically designed for high-resolution QTL mapping. It was created from a full reciprocal mating of five classical inbred strains (A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, and NZO/HlLtJ) and three wild-derived strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ) to capture a much greater level of genetic diversity than existing mouse genetic reference populations (GRPs) (Collaborative Cross Consortium 2012). Recently, we showed that CC lines respond differently to experimental periodontitis 42 d after mixed infection with P.g. and Fusobacterium nucleatum (F.n.) and enabled the mapping of confined QTLs that confer susceptibility to alveolar bone loss [3,20].
In the current study, we used the oral mixed-infection model of two periodontitis-related anaerobic bacteria, P.g. and F.n., to induce dysbiosis of the oral microbiota. We subsequently explored differences in microbiome composition and periodontal disease development in different CC lines with different genetic backgrounds.
2. Results
2.1. Susceptibility of CC Lines to Alveolar Bone Volume Affected by Oral-Mixed Infection
CC lines showed a significant variation in their response to the co-infection. Based on the one-way ANOVA, two lines (IL72, IL2513) showed a significant reduction in the mean of bone volume level after infection compared to the control group and were considered susceptible lines (p < 0.05), while four lines (IL211, IL188, IL1912, and IL3912) did not show significant bone loss after infection and were considered to be resistant lines (Figure 1). Noteworthy, line IL2126 showed a significant bone gain following the infection and is considered an over-resistant line.
2.2. Challenge Effect on Microbiome Compositional Shift
Alpha diversity was calculated for different variables at different levels, including susceptible and resistant lines, and at different time points (day 0, day 14, and day 42), including before and after infection. All of these comparisons were not significant (Figure 2). Beta diversity was calculated to assess the change in the diversity of species after infection for each line. A significant change in the species diversity was observed among the seven CC lines after infection (between time point one and the others time points), regardless of their susceptibility status (i.e., susceptible and resistant). However, no significant change was observed between day 14 and day 42 (Figure 2B and Figure 3A).
2.3. Microbiome Composition in Control Mice
Bacterial composition before infection (point time 1): Pasteurella and Streptococcus were the majority of the microbiome taxa for both susceptible and resistant lines. In addition, gram-positive taxa were significantly higher at the resistant lines compared to susceptible lines. In addition, the Streptococcus genus represented ~50% of the microbiome composition compared to ~25%. Some of the taxa were exclusive for susceptible lines (i.e., Saguibacteraceae) and were not shown in the flora of resistant lines, while others) i.e., Bradyrhizohiaceae and Bradyrhizobium) were present only in the resistant lines (Figure 3B and Figure 4A).
A total of 14 days after the mixed infection (point time 2), the microbiome composition for both susceptible and resistant mice was similar for the two major bacterial groups (Pasteurella and Streptococcus) but with significant proportional changes compared to time point 1. In addition, the bacteria are mainly gram-negative for both susceptible and resistant lines. Interestingly, the mixed cultures of P.g. and F.n. were not shown at this stage of post-infection status (Figure 4B and Figure 5A).
After 42 days of infection (point time 3), there was no significant change compared to 14 days after infection (time 2 point). Microbiome compositional changes were shown between resistant and susceptible lines; while some bacteria showed mainly in the susceptible lines, others were mainly present in the resistant ones. However, these changes were not significant (Figure 5B and Figure 6A).
2.4. Correlation between Alveolar Bone Loss and Dysbiosis
The abundance of Pasteuerlla and Bergeyella was positively correlated with bone loss in the susceptible lines (r = 0.78, 0.75, p < 0.0.5), suggesting a role in bone loss severity after infection, while Streptococcus and Pseudomonas show a negative correlation with bone loss (r= −0.79, −0.84, p < 0.0.5); the lower the number of bacteria is, the worse the disease severity was observed. This suggests the role of these bacteria in keeping bone volume levels healthy.
3. Discussion
The micro-CT results showed variations in the response of different CC lines to infection. Because the RILs were kept within the same controlled environment, we consider that this is related to the genetic differences between the RILs, which we assume are responsible for individual differences of the RILs in susceptibility to periodontal disease. Likewise, a previous study of our lab showed that the heritability tests for 23 CC lines that were challenged using the oral mixed infection model were 0.2. This implies that the variation in host susceptibility to the disease is influenced by genetic factors, as shown by the different phenotypes among the different RILs. For humans, twin studies estimated a heritability of 50% for periodontitis [21]. Each CC line responded differently to the infection according to the type and number of the SNPs in multiple candidate genes. Therefore, the phenotypes showed variation from mild to severe periodontitis or bone formation, which appeared in two CC lines instead of bone decreases. As we know, bone loss is a feature of the disease, but this new phenotype shows how genetic variability affects different genetic pathways, resulting in increased bone formation or resorption in response to bacterial challenge [3,22]. These results validate the power of the CC lines population for studying host genetic susceptibility to complex diseases with complex etiologies.
The 16 s microbiome sequencing showed that the beta diversity was distinctly different before and 42 days after infection. We also observed that resistant lines had a different microbiome compared to susceptible lines before infection. We consider this a valuable result because it gives some insight into how genetic predisposition shapes the microbiome and possibly indicates microbial compositions associated with resistance to infection-induced bone loss. In resistant lines, the gram-positive bacteria formed more than half of the microbiome compositions. This flora is associated with periodontal healthy tissues. It can influence the prevention of pathogenic colonization in different ways, e.g., by limiting the ability of pathogenic bacteria to adhere to appropriate tissue surfaces or by producing metabolic factors that are adverse to periodontal pathogens. After infection, gram-negative bacteria become dominant relative to the gram-positive bacteria, which may increase the susceptibility to periodontitis, resulting from specific virulence factors, which may consist of proteolytic enzymes that break down host tissue and may result in gingival inflammation, loss of gingival attachment, periodontal pocket formation, and alveolar bone and teeth destruction [23,24]. These results may support previous reports that showed that the composition and function of the indigenous oral microbiome may determine an alteration of the symbiotic interaction between the oral microbial community and the host with consequences for the oral and general health of the individual. The alteration of this finely tuned equilibrium between host and hosted microbes allows pathogenic bacteria to manifest their disease-promoting potential and determinate pathological conditions. Moreover, our results may fall in agreement with previous studies, which showed that the dynamic interactions between the various microbial and host factors that drive periodontal tissue destruction are not related to a limited number of periodontopathogenic species but are the outcome of a synergic action of dysbiotic microbial communities in the specific individual [10]. For example, P.g., one of the major etiologic microbial agents of periodontitis that we used in the current study and included in the Socransky Red Complex, requires iron and protoporphyrin IX from heme to survive and support dysbiosis initiation and development and the consequent onset of periodontal disease [25]. However, the changes in microbial diversity between health (eubiosis) and periodontal disease (dysbiosis) remain controversial since some researchers reported a loss of microbial diversity, others indicated an increasing level of microbial diversity, and still others did not report significant differences [26,27,28].
Interestingly, gram-positive bacteria were high in resistant lines before infection, and the Streptococcus genus represented half of the microbiome composition. Noteworthy, this genus is well known for its critical role in preventing pathogenic periodontal bacteria colonization (colonization resistance) and was proposed previously as a guided pocket recolonization approach as an alternative to the armamentarium of treatment options for periodontitis [29,30]. After infection, gram-positive bacteria decreased while gram-negative bacteria increased. These bacteria were not associated with alveolar bone loss, which may be related to many reasons. The bacteria did not produce a destructive host response, or microorganisms may lack some virulence factors responsible for periodontal tissue destruction. Notably, we observed that after infection, the genus Pseudomonas was reduced in susceptible but not resistant lines. Although speculative, this may indicate a protective role for periodontal tissue destruction.
Noteworthy, while this study demonstrates how the specific genetic background of the RIL shapes characteristics of the immune system and microbiome composition and may be used as a valuable tool for the dissection of the complex relationship, some limitations should be pinpointed. First, the microbiome composition in the current mouse population may not resemble the “natural” relationship of periodontitis to oral microbiome. This is because the dental plaque microbial community that forms on the supragingival area, which was collected in the present study, differs from the subgingival community, which is supposed to be more relevant to periodontal disease. However, collecting microbial samples from the periodontal pocket in the mouse model is almost unachievable. Second, during the sampling process, the samples were not always taken from the same mouse during the 3 points but from the same status and line and were not taken immediately after antibiotic treatment, which may have led to the loss of important information. Finally, in the current study, a small number of mice/lines were used to assess the utility of this model for exploring such complex phenotype; however, to dissect such a complex cause-effect relationship, we need to assess many more lines and mice per line.
In summary, microbiome analysis provides information regarding the differences in microbiome composition between resistant and susceptible RILs in health and disease independent of environmental factors. These data highlight the role of the genetic constitution in shaping the microbiome, thereby contributing to increased protection or risk of periodontal destruction. Future studies will characterize the underlying causal genetic variants and provide proof for the interrelations with specific bacterial taxa that influence oral health and disease. This may guide important preventive and therapeutic strategies for dental care.
4. Materials and Methods
All experiments were conducted at the Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University (TAU), Israel. All experimental mice and protocols were approved by the Institutional Animal Care and Use Committee of TAU (approval number: M-11-026), which adheres to the Israeli guidelines that are in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals, National Institute of Health (NIH), USA (National Academies Press; 8th edition). Full details of the CC lines were reported previously [31].
4.1. Bacterial Cultivation
The strains P.g 381 and F.n. 1594 were grown in peptone yeast extract containing hemin and vitamin K (Wilkins Chalgren broth, Oxoid Ltd., Hampshire, UK) in an anaerobic chamber with 85% N2, 5% H2, and 10% CO2 followed by three washes in phosphate-buffered saline PBS. The bacterial concentration was measured using spectrophotometry standardized to OD650 nm = 0.1 for P.g., corresponding to 1010 bacteria/mL [32,33], and OD660 nm = 0.26 for F.n., corresponding to 109 bacteria/mL.
4.2. Assessment of Lines Susceptibility to Alveolar Bone Loss
To assess the susceptibility of the CC lines to experimental periodontitis, we tested the alveolar bone changes among seven different lines (IL72, IL211, IL188, IL1912, IL2126, IL2513, and IL3912) after oral mixed infection by quantifying the alveolar bone volume using the micro-CT (μCT) technique. Figure 7 demonstrates the μCT assessment of two hemi-maxilla of two mice with different susceptibility statuses.
In total, we used 87 mice: 43 mice for the control and 44 mice for the challenge (a minimum of 5 mice were used per line in each group). Details are shown in Table 1:
Table 1
CC-Line | Infection | Control | Total |
---|---|---|---|
IL-72 | 5 | 5 | 10 |
IL-2126 | 5 | 5 | 10 |
IL-2513 | 8 | 5 | 13 |
IL-3912 | 5 | 6 | 11 |
IL-188 | 7 | 6 | 13 |
IL-211 | 6 | 6 | 12 |
IL-1912 | 8 | 10 | 18 |
4.3. Oral Mixed Infection Model and Micro-Computerized Tomography (CT) Analysis
Mice were treated with sulfamethoxazole (0.8 mg/mL) in drinking water for a continuous period of 10 days, followed by an antibiotic-free period of three days. Mixed cultures of P.g. and F.n. (400 uL of 109 bacteria/mL for each mouse) were prepared. Next, the infected groups were treated with the bacteria, while the control groups were treated with PBS and 2 carboxymethy cellulose at days 0, 2, and 4. Forty-two days post-infection, mice were euthanized after complete anesthesia, using xylisine (Sedaxylan) and ketamine (Clorketam). The infection challenge of the CC lines was carried out at the small animal facility at Tel-Aviv University (TAU). Susceptibility to alveolar bone loss-induced mixed infection among the selected lines was determined as previously described by our group. Briefly, maxillary jaws were harvested for micro-computed tomography (μCT) analysis, and alveolar bone loss was calculated proportionally to the alveolar bone volume of a control group (non-infected) of the same line [22].
4.4. Oral Microbiome Collection
Of the scanned 87 mice, 53 were used in the microbiome analysis: 53 oral swap samples and 53 from 7 different CC lines were collected and used for the microbiome assessment based on their susceptibility status (i.e., susceptible vs. resistant). Briefly, the biological samples for each status were collected at three points during the experiment and pooled for analysis. The oral samples were collected from mice at three groups/time points (point 1, day 0 (without infection); point 2, 14 days after infection; and point 3, 42 days after infection). Samples were collected using dry fine-tipped swabs and sterile paper points. The oral cavity of each mouse was swabbed for ~50 s (starting on the tongue, followed by buccal mucosa and gingiva). The swab was placed in empty Eppendorf tubes, swab handles were cut with sterile scissors, and samples were stored at −80 °C for further processing.
4.5. DNA Extraction and 16s rRNA Sequencing
The control (time point 1) and infected oral samples (time points 2 and 3) were used for DNA extraction using the Gene AllExgeneTM cell SV mini (100p/Catalog No:106-101/LotNo: 10618A26008) Kit. In total, 53 samples (15 samples at point 1, 17 at point 2, and 21 at point 3; details are shown in Table 2) were included and sequenced with the 16S sequencing library preparation protocol [34]. Briefly, after extracting pure DNA from the different samples, published primers were used to amplify the V3-V4 region of the bacterial 16S rRNA gene. PCR products were visualized following electrophoresis in agarose and staining with Gel Red™ to confirm a positive yield for each sample. Library preparation followed the Illumina library preparation protocol, with the following primers: forward CCTACGGGNGGCWGCAG and reverse GACTACHVGGGTATCTAATCC. Sequencing was carried out using Illumina Miseq at the Hadassah Medical School facility.
Table 2
Resistant Group | Susceptible Group | Total | |
---|---|---|---|
Control (Point 1—day 0; before infection) | 11 mice | 4 mice | 15 mice |
Point 2—14 days after infection | 13 mice | 4 mice | 17 mice |
Point 3—42 days after infection | 14 | 7 mice | 21 mice |
53 mice |
4.6. Microbiome Analysis
Reads with poor quality were filtered out, and after two filtration steps, the reads were reduced from 5194 to 67 taxa. Sequencing adapters and barcodes were trimmed, and each set of paired-end reads was merged into a single sequence (based on overlap). The sequences were assigned to individual samples with barcodes. Metagenomics workflow classified organisms from V3 and V4 amplicon using a database of 16S rRNA data. The classification is based on the Greengenes database (http://greengenes.lbl.gov/; accessed on 20 May 2020).
Data analysis was performed using the statistical software package MICC, v2 to produce operational taxonomic units (OTUs) at the genus level. Next, the phyloseq package of R was used to compute the number of OTUs and the Shannon diversity index, which is used to calculate the total number of species-level phylotypes. A one-way analysis of variance was used to test the significance of the difference between the treated groups. After significance was established, the inter-group differences were tested for significance using the t-test with the Shannon index for multiple testing. The level of significance was determined at a corrected significance threshold of p < 0.05.
4.7. Statistical Analysis
µCT data were analyzed using the statistical software package SPSS version 21. An analysis of variance (ANOVA) was performed to test the differences in response between the different CC lines. The level of significance was determined at p < 0.05. All results were presented as mean values and standard error of the mean.
Funding Statement
This report was supported by the German Research Foundation (DFG, Trilateral Project; SCHA 1582/4-1), Binational Science Foundation (BSF) grant number 2015077, German Israeli Science Foundation (GIF) grant I-63-410.20-2017, and Israeli Science Foundation (ISF) grant 1085/18.
Author Contributions
A.N. was involved in the study design, data collection and analysis, and writing the report; R.Q. was involved in data collection and analysis, and writing the report; R.H. was involved in the study design and data analysis; A.S. was involved in the study design, data analysis, and writing the manuscript; H.H. was involved in the study design, data analysis and writing the manuscrip; A.K. was involved in the study design, data analysis and writing the manuscript; Y.H.-H. was involved in the study design and data analysis and writing the manuscript: F.A.I. was involved in the study design, data analysis, and manuscript writing. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
All experiments were carried out at the Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University (TAU), Israel. All experimental mice and protocols were approved by the Institutional Animal Care and Use Committee of TAU (approval number: M-11-026), which adheres to the Israeli guidelines that are in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals, National Institute of Health (NIH), USA (National Academies Press; 8th edition).
Informed Consent Statement
Animals in this research are compatible with the national standards for the care and use of laboratory animals and were approved by the Institutional Animal Care and Use Committee (IACUC) of Tel Aviv University (approval numbers: 01-19-013 and 01-20-015), which adhered to the Israeli guidelines that follow the National Institutes of Health of USA animal care and use protocols.
Data Availability Statement
The data presented in this study are available on request from the corresponding author.
Conflicts of Interest
The authors declare that they have no conflicts of interest in this study and that no competing financial interests exist.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)
Citations & impact
Impact metrics
Article citations
The oral microbiome and oral and upper gastrointestinal diseases.
J Oral Microbiol, 16(1):2355823, 03 Jun 2024
Cited by: 2 articles | PMID: 38835339 | PMCID: PMC11149586
Review Free full text in Europe PMC
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Genotype is an important determinant factor of host susceptibility to periodontitis in the Collaborative Cross and inbred mouse populations.
BMC Genet, 14:68, 09 Aug 2013
Cited by: 29 articles | PMID: 23937452 | PMCID: PMC3751202
D-mannose alleviated alveolar bone loss in mice with experimental periodontitis via regulating the anti-inflammatory effect of amino acids.
J Periodontol, 94(4):542-553, 09 Nov 2022
Cited by: 3 articles | PMID: 36031720
Impaired salivary SIgA antibodies elicit oral dysbiosis and subsequent induction of alveolar bone loss.
Inflamm Res, 70(1):151-158, 09 Nov 2020
Cited by: 9 articles | PMID: 33165644
Microbial signatures of health, gingivitis, and periodontitis.
Periodontol 2000, 86(1):57-78, 10 Mar 2021
Cited by: 122 articles | PMID: 33690899
Review
Funding
Funders who supported this work.
Binational Science Foundation (1)
Grant ID: 2015077
Deutsche Forschungsgemeinschaft (1)
Grant ID: SCHA 1582/4-1
German Israeli Science Foundation (1)
Grant ID: I-63-410.20-2017
German Research Foundation (1)
Grant ID: SCHA 1582/4-1
German-Israeli Foundation for Scientific Research and Development (1)
Grant ID: 63-410.20-2017
Israel Science Foundation (1)
Grant ID: 1085/18
Israeli Science Foundation (1)
Grant ID: 1085/18
United States-Israel Binational Science Foundation (1)
Grant ID: 2015077